Archives
-
0.4% Trypan Blue Solution: Cell Viability Guide
2026-09-13
0.4% Trypan Blue Solution supports rapid live/dead cell discrimination and cell viability measurement during cell counting, culture maintenance, and endpoint cytotoxicity workflows. It is intended for research use only, not for diagnostic or medical applications, and should be interpreted as a membrane-integrity assay rather than a complete apoptosis or necrosis classification method.
-
Live-Dead Bacterial Staining Kit for Nanomaterial Assays
2026-09-12
The Live-Dead Bacterial Staining Kit transforms nanoparticle antimicrobial testing into an interpretable membrane-integrity readout. This guide explains how NucGreen dye and EthD-III can distinguish bacterial injury from true viability loss while exposing important assay limitations.
-
Staurosporine Workflows for Cell Signaling
2026-09-11
Build more interpretable apoptosis and kinase-signaling assays with Staurosporine, while controlling DMSO exposure, cell-state variation, and post-thaw recovery. A cryopreservation study adds practical guidance for developing assay-ready THP-1 workflows and reducing well-to-well variability.
-
Puromycin aminonucleoside for Podocyte Injury Models
2026-09-11
Build reproducible podocyte injury, proteinuria, and glomerular lesion workflows with a nephrotoxic aminonucleoside designed for mechanistic renal research. This guide combines practical assay setup, storage and dosing considerations, stage-aware controls, and troubleshooting for in vitro and animal studies.
-
Comparative Gene Expression in Mammalian Claustrum
2026-09-10
This study combines gene expression, cytoarchitecture, and anatomical position to identify conserved claustrum subdivisions across rats, shrews, and primates. Its comparative framework offers a stronger basis for interpreting claustrum organization beyond mouse models and for relating molecular boundaries to brain structure and function.
-
Lypressin Acetate: From Receptor Biology to Translation
2026-09-10
Lypressin acetate links vasopressin receptor pharmacology with antidiuretic, vasopressor, and emerging antiviral research. This translational guide shows how to validate its mechanism, design reproducible assays, interpret clinical relevance, and evaluate the SARS-CoV-2 RdRp hypothesis without overstating maturity.
-
Hepatic sEH–Nrf2 Signaling in Osteoporosis
2026-09-09
A 2025 study identifies a liver–bone axis in which hepatic soluble epoxide hydrolase alters circulating epoxyeicosatrienoic acid metabolites and inflammatory signals, thereby suppressing Nrf2-ARE activity and promoting osteoclast differentiation. Its combination of clinical observations, ovariectomy-induced osteoporosis, liver-specific gene manipulation, metabolite analysis, and transcriptomics provides a mechanistic framework for studying redox imbalance in bone disease.
-
Cisapride (R 51619): A Translational Stress Test
2026-09-09
Cisapride, also known as R 51619, offers a powerful translational model because its nonselective 5-HT4 receptor agonism intersects with potent hERG channel inhibition. This article shows how to deploy that dual pharmacology in cardiac electrophysiology research, iPSC-derived cardiomyocyte screening, and mechanistic safety workflows without confusing pathway activity with clinical prediction.
-
Sulfisomidine: From Folate Biology to hPON1
2026-09-08
Sulfisomidine, also known as sulfamethin, offers translational researchers a useful bridge between bacterial folate-pathway biology and human serum paraoxonase 1 inhibition. This thought-leadership guide explains how to position the compound in microbial assays, enzyme kinetics, oxidative stress regulation research, and strategically controlled translational workflows.
-
Spleen-Targeted Neoantigen mRNA Vaccine in HCC
2026-09-08
Lin et al. developed a spleen-targeted neoantigen mRNA vaccine that produced strong antitumor activity in orthotopic hepatocellular carcinoma models and identified ISG15-positive CD8-positive T cells as key effectors. The study links these cells to tertiary lymphoid structure formation through GZMA-F2R interactions with antigen-presenting cells, providing a mechanistic framework for evaluating spleen-directed mRNA vaccine design.
-
AZD1480: A Practical JAK2 Inhibitor Workflow
2026-09-07
AZD1480 enables compartment-resolved testing of tumor-intrinsic JAK2/STAT3 activation, from cytokine stimulation and immune–tumor co-culture to myeloma and solid-tumor assays. This workflow emphasizes pathway validation, concentration optimization, combination testing, and troubleshooting rather than relying on viability data alone.
-
In Vitro Drug Response Metrics in Cancer Research
2026-09-07
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but not interchangeable drug-response outcomes. The work supports time-resolved, multidimensional in vitro assays that improve interpretation of cytostatic and cytotoxic effects across cancer models.
-
TH287 MTH1 Inhibitor: Radiosensitization Workflow
2026-09-05
TH287 turns oxidized nucleotide stress into a measurable cancer-cell vulnerability and provides a timing-sensitive approach to radiosensitization research. This practical guide connects MTH1 inhibition with viability, apoptosis, DNA-damage, and cell-cycle assays while highlighting formulation, scheduling, and interpretation controls.
-
Dabigatran Workflows for Thrombin Assays
2026-09-04
Dabigatran provides a reversible, mechanism-defined way to interrogate thrombin activity across enzyme, plasma, and clot-based models. This guide connects practical assay workflows with catalpol-focused cardiovascular research while emphasizing formulation control, quantitative analysis, and translational limits.
-
Hexetidine Mouthrinses: In Vitro and In Vivo Evidence
2026-09-04
The 1981 Roberts and Addy study compared hexetidine with chlorhexidine, alexidine, and cetyl pyridinium chloride using MIC testing, protein-rich media, and salivary measurements in human volunteers. Its central contribution was showing that in vitro potency, susceptibility to oral environmental components, and persistence in saliva are distinct properties that can influence interpretation of oral antiseptic performance.